Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

UBS
Cerilliant
Covington
McKesson
Fish and Richardson
Chubb
Accenture
Queensland Health
Deloitte
Boehringer Ingelheim

Generated: August 22, 2017

DrugPatentWatch Database Preview

Samarium sm-153 lexidronam pentasodium - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for samarium sm-153 lexidronam pentasodium and what is the scope of samarium sm-153 lexidronam pentasodium freedom to operate?

Samarium sm-153 lexidronam pentasodium
is the generic ingredient in one branded drug marketed by Lantheus Medical and is included in one NDA. Additional information is available in the individual branded drug profile pages.

Two suppliers are listed for this compound.

Summary for Generic Name: samarium sm-153 lexidronam pentasodium

Tradenames:1
Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list2
Clinical Trials: see list36
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:samarium sm-153 lexidronam pentasodium at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lantheus Medical
QUADRAMET
samarium sm-153 lexidronam pentasodium
INJECTABLE;INJECTION020570-001Mar 28, 1997RXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: samarium sm-153 lexidronam pentasodium

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Lantheus Medical
QUADRAMET
samarium sm-153 lexidronam pentasodium
INJECTABLE;INJECTION020570-001Mar 28, 1997► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Cipla
Medtronic
McKinsey
Queensland Health
Cerilliant
Chinese Patent Office
Julphar
AstraZeneca
QuintilesIMS
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot